Valuation Metrics Show Improved Price Attractiveness
India Glycols currently trades at a price of ₹1,084.60, down 5.21% on the day from a previous close of ₹1,144.20. Despite this short-term weakness, the company’s valuation metrics have improved significantly. The price-to-earnings (P/E) ratio stands at 24.78, which is considerably lower than many of its peers in the commodity chemicals sector, several of whom are classified as very expensive with P/E ratios ranging from 30.62 to 88.27.
Similarly, the price-to-book value (P/BV) ratio of 2.48 is modest compared to sector heavyweights, indicating a more reasonable price relative to the company’s net asset value. This contrasts with peers such as Navin Fluorine International and Himadri Speciality Chemical, which trade at much higher multiples, reflecting stretched valuations.
Peer Comparison Highlights Relative Value
When benchmarked against its peers, India Glycols emerges as an attractive option. For instance, Navin Fluorine International trades at a P/E of 52.96 and an EV/EBITDA of 34.15, while Himadri Speciality Chemical’s P/E is 48.74 with an EV/EBITDA of 38.67. In contrast, India Glycols’ EV/EBITDA ratio is a more moderate 13.72, underscoring its relative affordability.
The PEG ratio of 1.43 further supports the valuation appeal, suggesting that the stock’s price is reasonable relative to its earnings growth prospects. This is particularly notable given that some peers have PEG ratios as high as 19.20, indicating potential overvaluation.
Financial Performance and Returns Support Valuation
India Glycols’ return on capital employed (ROCE) and return on equity (ROE) stand at 10.80% and 10.00% respectively, reflecting stable operational efficiency and shareholder returns. While these figures are not sector-leading, they are consistent and provide a solid foundation for the current valuation.
Dividend yield at 1.12% adds a modest income component for investors, complementing the company’s growth profile. The enterprise value to capital employed ratio of 1.95 and EV to sales of 2.12 further indicate a balanced valuation relative to the company’s asset base and revenue generation.
Stock Performance Outpaces Sensex Over Medium to Long Term
India Glycols has delivered robust returns over multiple time horizons, significantly outperforming the Sensex. Year-to-date, the stock has gained 6.44% compared to the Sensex’s decline of 7.84%. Over one year, the stock surged 24.66% while the benchmark fell 1.65%. The three-year and five-year returns are particularly impressive at 207.56% and 210.57% respectively, dwarfing the Sensex’s 19.57% and 43.97% gains over the same periods.
Most strikingly, the ten-year return of 2,211.10% highlights the company’s exceptional long-term growth trajectory, far exceeding the Sensex’s 182.78% over the decade. This performance underpins the current valuation upgrade and investor confidence in the company’s prospects.
This week's disclosed pick, a Large Cap from NBFC, comes with precise Target Price and analysis. Check if you're positioned right for this opportunity!
- - Precise target price set
- - Weekly selection live
- - Position check opportunity
MarketsMOJO Rating Upgrade Reflects Changing Market Perception
On 20 May 2026, MarketsMOJO upgraded India Glycols’ Mojo Grade from Sell to Hold, with a current Mojo Score of 50.0. This upgrade reflects the improved valuation parameters and the company’s stable fundamentals. The small-cap designation remains, but the shift in rating signals a more favourable outlook from analysts.
Despite the recent one-day decline of 5.21%, the stock’s valuation attractiveness and solid returns profile suggest that the dip may present a buying opportunity for investors seeking exposure to the commodity chemicals sector at a reasonable price.
Sector Context and Risks
The commodity chemicals sector remains volatile, influenced by raw material price fluctuations, regulatory changes, and global demand cycles. While India Glycols’ valuation is attractive relative to peers, investors should remain mindful of sector headwinds that could impact near-term earnings.
Moreover, the company’s ROCE and ROE, while stable, do not indicate exceptional profitability, which may limit upside potential if sector conditions deteriorate. Nonetheless, the current valuation discount to peers provides a margin of safety.
Holding India Glycols Ltd from Commodity Chemicals? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Conclusion: Valuation Shift Enhances Investment Appeal
India Glycols Ltd’s transition from a fair to an attractive valuation grade marks a significant development for investors evaluating commodity chemicals stocks. The company’s lower P/E and P/BV ratios relative to peers, combined with solid long-term returns and a recent Mojo Grade upgrade, suggest that the stock is favourably positioned for investors seeking value in this sector.
While sector risks remain, the valuation discount and consistent financial metrics provide a compelling case for inclusion in a diversified portfolio. Investors should monitor market conditions and company performance closely but may find the current price level an opportune entry point given the stock’s historical outperformance and improved market perception.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
